Oryzon Genomics SA(ES:ORY)
€2.58+0.10 (+4.12%)
ES:ORY
Oryzon Genomics SA financials statements
€2.58
At close:+0.10 (+4.12%)
Want to see ES:ORY full AI Analyst Report?
Oryzon Genomics SA (ORY) Income Statement
35 Followers
Oryzon Genomics SA Income Statement
Last quarter (Q1 2026), Oryzon Genomics SA's total revenue was €0.00. In Q1, Oryzon Genomics SA's net income was €-1.22M. See Oryzon Genomics SA’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| € 0.00 | € 7.36M | € 14.19M | € 0.00 | € 10.62M | |
| € -133.91K | € 7.06M | € 13.95M | € 15.23M | € 9.87M | |
| € 6.29M | € 11.48M | € 18.50M | € 20.72M | € 16.88M | |
| Depreciation and Amortization | € 133.91K | € 147.75K | € 152.88K | € 166.66K | € 144.33K |
| € -6.29M | € -4.43M | € -4.41M | € -5.33M | € -6.88M | |
| € -6.42M | € -4.42M | € -4.55M | € -5.49M | € -7.01M | |
| € 820.43K | € -1.15M | € -1.55M | € -1.07M | € -169.00K | |
| € -5.60M | € -5.57M | € -6.10M | € -6.56M | € -7.18M | |
| € -2.61M | € -3.67M | € -3.35M | € -4.23M | € -4.69M | |
| Per Share Metrics | |||||
| Basic EPS | € -0.04 | € -0.06 | € -0.06 | € -0.08 | € -0.09 |
| Diluted EPS | € -0.04 | € -0.06 | € -0.06 | € -0.08 | € -0.09 |
| Weighted Average Shares Outstanding | 74.37M | 64.37M | 60.88M | 56.04M | 52.76M |
| Weighted Average Shares Outstanding (Diluted) | 74.37M | 64.37M | 60.88M | 56.04M | 52.76M |
Currency in EUR
